159 related articles for article (PubMed ID: 12176556)
1. Usefulness of monitoring of AUC(0-4h) during the induction period of immunosuppressive therapy with tacrolimus after renal transplantation.
Uchida K; Tominaga Y; Haba T; Katayama T; Matsuoka S; Sato T; Goto N; Takeda A; Morozumi K; Takagi H
Transplant Proc; 2002 Aug; 34(5):1736-7. PubMed ID: 12176556
[No Abstract] [Full Text] [Related]
2. The roles of C4 and AUC0-4 in monitoring of tacrolimus in stable kidney transplant patients.
Pisitkun T; Eiam-Ong S; Chusil S; Praditpornsilpa K; Pansin P; Tungsanga K
Transplant Proc; 2002 Dec; 34(8):3173-5. PubMed ID: 12493410
[No Abstract] [Full Text] [Related]
3. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
Braun F; Schütz E; Peters B; Talaulicar R; Grupp C; Undre N; Schäfer A; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 2001 May; 33(3):2127-8. PubMed ID: 11377473
[No Abstract] [Full Text] [Related]
4. Specificity of therapeutic drug monitoring of tacrolimus in kidney transplant patients.
Sato S; Fuchinoue S; Tojimbara T; Fujita S; Nakajima I; Agishi T; Hayashi T; Teramura Y; Fujita E; Iwasaki K
Transplant Proc; 1998 Jun; 30(4):1274-5. PubMed ID: 9636517
[No Abstract] [Full Text] [Related]
5. Long-term outcome of tacrolimus rescue therapy in late rejection after renal transplantation.
Budde K; Smettan S; Fritsche L; Waiser J; Giessing M; Kunz R; Türk I; Bauer S; Mai I; Neumayer HH
Transplant Proc; 1998 Aug; 30(5):1780-1. PubMed ID: 9723280
[No Abstract] [Full Text] [Related]
6. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. European Tacrolimus Multicentre Renal Study Group.
Undre NA; Schäfer A
Transplant Proc; 1998 Jun; 30(4):1261-3. PubMed ID: 9636512
[No Abstract] [Full Text] [Related]
7. Tacrolimus monitoring by simplified sparse sampling under the concentration time curve.
Balbontin FG; Kiberd B; Squires J; Singh D; Fraser A; Belitsky P; Lawen J
Transplant Proc; 2003 Nov; 35(7):2445-8. PubMed ID: 14611982
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of multiple drug therapy including tacrolimus in clinical renal transplantation.
Okamoto M; Yoshimura N; Nakai I; Nakajima H; Ushigome H; Sakaguchi K; Ohmori Y; Yoshimura R; Sugioka N; Oka T
Transplant Proc; 2000 Nov; 32(7):1716-7. PubMed ID: 11119905
[No Abstract] [Full Text] [Related]
9. Defining the initial doses of sirolimus and tacrolimus in the period immediately after renal transplantation.
Jiménez O; Campistol JM; Vidal E; Faura A; Oppenheimer F; Corbella J; Brunet M
Transplant Proc; 2003 Aug; 35(5):1686-8. PubMed ID: 12962758
[No Abstract] [Full Text] [Related]
10. Long-term stable glomerular filtration rate achieved with tacrolimus in pediatric renal transplantation.
Pape L; Henne T; Strehlau J; Latta K; Ehrich JH; Offner G
Transplant Proc; 2002 Sep; 34(6):2211-2. PubMed ID: 12270367
[No Abstract] [Full Text] [Related]
11. Clinical pharmacokinetics of tacrolimus after the first oral administration in combination with mycophenolate mofetil and prednisone in Chinese renal transplant recipients.
Chen YH; Zheng KL; Chen LZ; Dai YP; Fei JG; Qiu J; Li J
Transplant Proc; 2005 Dec; 37(10):4246-50. PubMed ID: 16387090
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus.
Oellerich M; Armstrong VW; Schütz E; Shaw LM
Clin Biochem; 1998 Jul; 31(5):309-16. PubMed ID: 9721427
[No Abstract] [Full Text] [Related]
13. Therapeutic drug monitoring of tacrolimus in kidney transplantation: 9-month follow-up.
Brunet M; Torregrosa JV; Oppenheimer F; Corbella J
Transplant Proc; 1998 Dec; 30(8):4068-9. PubMed ID: 9865298
[No Abstract] [Full Text] [Related]
14. Two-hour blood tacrolimus levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal transplant patients.
Jørgensen KA; Povlsen JV; Madsen S; Madsen M; Hansen HE; Pedersen AR; Heinsvig EM; Poulsen JH
Transplant Proc; 2002 Aug; 34(5):1721-2. PubMed ID: 12176551
[No Abstract] [Full Text] [Related]
15. Follow the Area Under the Curve Not the Trough Concentration: A Case Study of Tacrolimus Monitoring in a Kidney Transplant Recipient Cotreated With Phenobarbital.
Izarn O; Morin MP; Ntobe-Bunkete B; Golbin L; Ferrand-Sorre MJ; Tron C; Lemaitre F
Ther Drug Monit; 2024 Jun; 46(3):285-287. PubMed ID: 38648637
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring of tacrolimus early after liver transplantation.
Braun F; Peters B; Schütz E; Lorf T; Undre N; Oellerich M; Ringe B
Transplant Proc; 2002 Aug; 34(5):1538-9. PubMed ID: 12176473
[No Abstract] [Full Text] [Related]
17. How to handle mycophenolate mofetil in combination with tacrolimus?
Braun F; Canelo R; Schütz E; Shipkora M; Lorf T; Hanack U; Niedmann D; Armstrong VW; Oellerich M; Ringe B
Transplant Proc; 1998 Dec; 30(8):4094-5. PubMed ID: 9865309
[No Abstract] [Full Text] [Related]
18. Tacrolimus vs CyA Neoral in combination with MMF and steroids after cadaveric renal transplantation.
Wang XH; Tang XD; Xu D
Transplant Proc; 2000 Nov; 32(7):1702-3. PubMed ID: 11119899
[No Abstract] [Full Text] [Related]
19. Elimination of the adverse effects of tacrolimus-based induction therapy by a 5-day exposure of optimal steady-state blood concentration in renal transplant patients in the early postoperative period.
Ishibashi M; Miyamoto S; Nojima M; Yoshimoto T; Yabumoto H; Mori Y; Shima H
Transplant Proc; 1999 Nov; 31(7):2761-2. PubMed ID: 10578281
[No Abstract] [Full Text] [Related]
20. Japanese single-center experience of kidney transplantation under tacrolimus immunosuppression.
Tanabe K; Tokumoto T; Ishikawa N; Shimizu T; Okuda H; Ito S; Shimmura H; Inui M; Harano M; Manu M; Koga S; Ohtsubo S; Suzuki K; Shiroyanagi Y; Goya N; Nakazawa H; Yagisawa T; Nakajima I; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1696-9. PubMed ID: 11119897
[No Abstract] [Full Text] [Related]
[Next] [New Search]
